The Carlat Psychiatry Podcast
To Benzo, or not to Benzo: An Interview with Carl Salzman
Carl Salzman removes the stigma from the much aligned benzo, reminding us of when they are essential to treatment and when they cause harm. Dr. Salzman is the past chairman of the American Psychiatric Association’s Benzodiazepine Task Force.
Published On: 07/18/2022
Duration: 22 minutes, 06 seconds
Referenced Article: “Benzodiazepines: A Reevaluation of Their Benefits and Dangers,” The Carlat Child Psychiatry Report, June 2022 Chris Aiken, MD, Kellie Newsome, PMHNP, and Carl Salzman, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.